Viracta Therapeutics Inc (NASDAQ:VIRX)
| 1.45 Delayed Data As of 3:59pm ET |  +0.04 / +2.84%Today’s Change | 0.88 Today|||52-Week Range 5.75 | -0.68% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -36.7M | -38.0M | -35.5M | -26.6M | |
| Depreciation | 27.0K | 11.0K | 9.0K | 9.0K | ||
| Total Other Cash Flow | 2.9M | 5.2M | 3.3M | 2.8M | ||
| Funds From Operations | -33.7M | -32.8M | -32.1M | -23.8M | ||
| Funds From/For Other Operating Expenses | 5.0M | 4.1M | 4.0M | 627.0K | ||
| Net Cash Flow - Operating Activities | -38.7M | -37.0M | -36.1M | -24.4M | ||
| Investing | Increase In Investments | -35.7M | -35.5M | 0.00 | 0.00 | |
| Decrease In Investments | 36.9M | 20.5M | 29.8M | 4.8M | ||
| Capital Expenditures | 0.00 | 0.00 | -26.0K | 0.00 | ||
| Net Cash Flow Investing | 1.2M | -15.0M | 29.7M | 4.8M | ||
| Financing | Short Term Borrowings | -- | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 14.7M | 0.00 | 0.00 | ||
| Long Term Debt Reduction | -1.6M | -8.0M | -7.6M | 0.00 | ||
| Net Proceeds Stock Sale | 43.8M | 26.4M | 32.9M | 6.3M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 42.2M | 33.1M | 25.3M | 6.3M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 4.7M | -18.8M | 18.9M | -13.3M | ||
